Introduction
1,2,3-Thiadiazoles and tetrazoles are important heterocyclic compounds, both present a wide spectrum of biological activities. 1,2,3-Thiadiazoles have antitumor [1] , antiviral [2] , fungicidal [3, 4] , antibacterial [5] and insecticidal [6] activities. Successful commercialization of some 1,2,3-thiadiazoles such as tiadinil (TDL) [7] and acibenzolar-S-methyl (BTH) [8] as elicitors accelerated the studies of their synthesis and systemic acquired resistance (SAR). [9] [10] [11] Tetrazoles and their derivatives have been reported as antibacterial [12] , antiviral [13] , herbicidal [14] , anti-inflammatory [15] antitumor [16] , analgesic [17] , and antiproliferative [18] agents. There are many reports about each of the two heterocyclics, but the combination of 1,2,3-thiadiazole ring with tetrazole ring in one molecule is seldom reported both in chemistry and their biological activity studies.
Multicomponent reactions (MCRs), in which three or more reactants in one pot generate products containing almost all atoms of the reactant molecules, have been developed extensively as tools to achieve highly atom-, step-, and energy-economic organic synthesis [19] . Among the MCRs, the Ugi four-component condensation reaction (U-4CR) features many applications in organic syntheses and medicinal chemistry [20, 21] . The classical U-4CR between amine, aldehyde, carboxylic acid and isocyanide affords peptidic structures in high diversity. The Ugi-tetrazole synthesis is a variation of the classical Ugi-reaction where azidotrimethylsilane (TMSN 3 ) is employed as an acid component [22] and this synthetic strategy has been applied to the synthesis of various 1,5-disubstituted tetrazoles [23, 24] . To develop novel candidate pesticides with diverse biological activities, tetrazole moiety was introduced into 1,2,3-thiadizole, and a series of novel tetrazole containing 1,2,3-thiadiazole derivatives were designed and synthesized via U-4CR. Their antivirus activities against tobacco mosaic virus (TMV) were also evaluated.
Experimental
Melting points of all compounds were determined on an X-4 binocular microscope (Gongyi Technical Instrument Co., Henan, China), and the thermometer was not corrected. Proton NMR spectra were obtained using a Bruker AVANCE-400 MHz spectrometer, and chemical shift values (d) were reported as parts per million (ppm) with deuteron chloroform (CDCl 3 ) as the solvent and tetramethylsilane (TMS) as the internal standard. High resolution mass spectrometry (HRMS) data were obtained on an FTICR-MS Varian 7.0T FTICR-MS instrument. All the reagents were obtained commercially and used after further purification. Column chromatography purification was carried out by using silica gel.
General procedure for synthesis of compounds 4a-4m (Scheme 1): 4-Methyl-1,2,3-thiadiazole-5-carbaldehyde 3 (0.21 g, 1.6 mmol) and substituted amine (1.6 mmol) were stirred in 8 mL methanol at room temperature. The imine was precondensated for 0.5-1 h and then cyclohexyl isocyanide (0.21 g, 1.9 mmol) and TMSN 3 (0.28 g, 2.4 mmol) were added. The reaction mixture was stirred for 12-24 h at room temperature until the reaction was completed (indicated by TLC). Then the organic solvent was evaporated in vacuo. The crude products were purified by a silica gel column using ethyl acetate/petroleum ether (1:2-1:3 (v/v), 60-90 8C) as an eluent to give 4a-4m as white or pale yellow solids in moderate yields.
Direct anti-TMV activity of target compounds 4a-4m was conducted by half leaf juice robbing methods according to Ref. [25] . Protection effect against TMV in vivo was evaluated on N. tabacum L. leaves [4] . Healthy fresh tobacco plants at the six-leaf stage were selected for the tests. The compound solution was smeared on the whole leaves, and then the leaves were dried in the greenhouse. After 12 h, TMV at a concentration of 5.88 Â 10 À2 mg/ mL was inoculated on the upper three leaves using the conventional juice robbing method, and the solvent was smeared on the lower three leaves as a control. The local lesion numbers were then recorded 2-3 days after inoculation. For each compound, three repetitions were conducted. All compounds were tested at concentrations of 100 mg/mL. Ribavirin and ningnanmycin were used as positive control at the same time. The activity data of protection effect against TMV was calculated by the following equation:
where Y is the antivirus inhibition ratio (%), CK is the average number of viral inflammations on the control leaves in vivo, and A is the average number of viral inflammations on the target compound treated leaves in vivo.
Results and discussion
The synthesis route of the target compounds was outlined in Scheme 1. The starting material, ethyl 4-methyl-1,2,3-thiadiazole-5-carboxylate 1, was prepared according to Ref. [9] . Cyclohexyl isocyanide was synthesized according to Ref. [4] . The intermediate (4-methyl-1,2,3-thiadiazol-5-yl)methanol 2 was obtained in high yields by reduction of 1 with NaBH 4 at 0 8C to room temperature. Treatment of a intermediate 2 with pyridinium chlorochromate at room temperature produced 4-methyl-1,2,3-thiadiazole-5-carbaldehyde 3 in 86% yields. The target compounds 4a-4m were obtained by the U-4CR of 3 with substituted amines, cyclohexyl isocyanide and TMSN 3 in methanol in moderate yields, which were white or pale yellow solid after column chromatography purification.
The structures of the target compounds synthesized herein were fully characterized by melting points, 1 H NMR, IR, and HRMS (ESI) [26] . In the IR spectra of compounds 4a-4m, strong absorptions at about 3300 cm À1 were detected, due to the secondary amino group. In the 1 H NMR spectra, CH 3 of 1,2,3-thiadizole were observed at d 2.57-2.66. Furthermore, a doublet signal at about d 4.80 due to the NH proton coupled with the aromatic proton at about d 7.00 as seen for compounds 4i-4m; as for compounds 4a-4h, the NH proton doublet was not always clearly detected because of overlapping with the aliphatic protons. The HRMS (ESI) spectral data of all compounds are in good agreement with theoretical data. The results of direct anti-TMV activity and protection effect of all target compounds were listed in Table 1 . As shown in the data, most compounds have very good anti-TMV activity at 100 mg/mL, which were equal to or higher than that of the positive control ribavirin. Among them, compound 4l showed excellent anti-TMV activity with inhibition activity of 48.73%, which was higher than that of ninamycin. Besides possessing good direct anti-TMV activity, compounds 4b, 4c and 4i also presented very good protection effect in vivo at 100 mg/mL, which were equivalent to the positive control ribavirin. After a structural comparison, it was very clear that the whole molecular structure played an important role in anti-TMV activity rather than one moiety in the molecule. Our results indicate that the combination of 1,2,3-thiadiazole ring with tetrazole ring in one molecule can improve their biological activities. This provides us with useful clues for further research of finding novel leading structures possessing good antivirus activity based on the structure reported in this paper.
Conclusion
In summary, a series of novel tetrazole containing 1,2,3-thiadiazole derivatives were synthesized via a simplified Ugitetrazole reaction and easily purified. The bioassay tests indicated that most target compounds have higher anti-TMV activity than that of ribavirin did at 100 mg/mL. Compounds 4b, 4c and 4i also showed equivalent protection effect to ribavirin in vivo at 100 mg/ mL. These studies indicate that the newly synthesized tetrazole containing 1,2,3-thiadiazole derivatives possessed good potential bioactivities, and were worthy of further study in pesticide development. 
